Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the change in glycemic control, as measured by
hemoglobin A1c (HbA1c) from baseline to study week 24, in subjects receiving insulin
glulisine as mealtime insulin following a variable bolus insulin regimen (based on
carbohydrate counting) versus a fixed bolus insulin regimen, with insulin glargine as basal
insulin in both arms of the study.